AstraZeneca bulks up Imfinzi's prowess with FDA nod in bladder cancer around surgery

31st March 2025 Uncategorised 0

Imfinzi is the first immunotherapy cleared in the U.S. to treat muscle-invasive bladder cancer patients before and after bladder removal surgery, making for a new treatment option in a disease with high rates of recurrence.

More: AstraZeneca bulks up Imfinzi's prowess with FDA nod in bladder cancer around surgery
Source: fierce